A.R.T. Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

A.R.T. Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,399	Closed	-$84K	–	1792
2019 Q3	$84K	Sell	23,399 -6,500	-22%	-$23K	﹤0.01%	1278
2019 Q2	$101K	Buy	+29,899	New	+$105K	0.01%	1192
2018 Q4	–	Sell	-20,282	Closed	-$83K	–	1722
2018 Q3	$83K	Buy	+20,282	New	+$92.1K	﹤0.01%	1290
2018 Q2	–	Sell	-21,007	Closed	-$115K	–	1811
2018 Q1	$115K	Buy	+21,007	New	+$148K	﹤0.01%	1344
2017 Q3	–	Sell	-10,573	Closed	-$116K	–	1726
2017 Q2	$116K	Buy	+10,573	New	+$98.5K	0.01%	1237
2016 Q3	–	Sell	-17,061	Closed	-$101K	–	1214
2016 Q2	$101K	Buy	+17,061	New	+$94.7K	0.01%	1208
2014 Q4	–	Sell	-13,625	Closed	-$70K	–	1704
2014 Q3	$70K	Buy	13,625 +1,500	+12%	+$8K	﹤0.01%	1229
2014 Q2	$63K	Buy	+12,125	New	+$52.4K	﹤0.01%	1246

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

A.R.T. Advisors's ENZ Position: Q4 2019 in Review

A.R.T. Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q4 2019, closing a stake of 23,399 shares — an estimated $84K sold.

A.R.T. Advisors first reported a position in ENZ in Q2 2014 and held it in 8 quarters. The position peaked at $116K in Q2 2017. 81 funds tracked by Wall St. Rank hold ENZ as of Q4 2019.

A.R.T. Advisors reported no remaining Enzo Biochem, Inc. position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 23,399 Enzo Biochem, Inc. shares in Q4 2019, an estimated $84K.
A.R.T. Advisors first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 8 quarters.
A.R.T. Advisors's Enzo Biochem, Inc. position peaked at $116K in Q2 2017.
81 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.